Skip to content
★ Sign in to follow
SJ

Sir Jonathan Symonds

Chairman
GlaxoSmithKline plc
Total declarations
14
Company
1
▲ Purchases (13 ops.)
€1.0M
▼ Sales (1 ops.)
€130k

Latest filing published 24 Jun 2022 for GlaxoSmithKline plc, €51k.

Filing timeline

BuySale
Sir Jonathan Symonds

Insider track record

Disclosed buys
13
Disclosed sells
1
Signal history

Closed purchases

Market purchases
13

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Sir Jonathan Symonds: trading record in brief

Sir Jonathan Symonds appears in our data through filings on GlaxoSmithKline plc shares, published by RNS (LSE). In total, 14 filings cover trades dated from 5 February 2020 to 23 June 2022.

The open-market side counts 13 purchases for €1.0M alongside 1 sale for €130k. Taken together, the purchases exceed the sales by €880k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2022: 2 purchases and no sales on the market.

The median purchase comes to €51k.

Most recently, on 24 June 2022, the filings show an open-market purchase worth €51k in GlaxoSmithKline plc. The median gap between a trade and its publication by RNS (LSE) is 1 day. For comparison, UK MAR gives managers three business days to notify a trade. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Sir Jonathan Symonds

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations14 total
  • ▲
    Non-Executive ChairExecutivesGlaxoSmithKline plc
    43,750 GBP0FCA-NSM
    2,587.226 shares@ £16.914.5% of flowN/AISIN GB0009252882FCA-NSM:4417125-0
    Canonical exit: 21 Sept 2022 (T+90)
  • ▲
    Non-Executive ChairExecutivesGlaxoSmithKline plc
    43,754 GBP0FCA-NSM
    2,751.797 shares@ £15.904.6% of flowN/AISIN GB0009252882FCA-NSM:4313462-0
    Canonical exit: 21 Jun 2022 (T+90)
  • ▲
    Non-Executive ChairExecutivesGlaxoSmithKline plc
    43,750 GBP0FCA-NSM
    2,710.657 shares@ £16.144.5% of flowN/AISIN GB0009252882FCA-NSM:4220643-0
    Canonical exit: 20 Mar 2022 (T+90)
  • ▲
    Non-Executive ChairmanExecutivesGlaxoSmithKline plc
    43,750 GBP0FCA-NSM
    3,138.451 shares@ £13.944.5% of flowN/AISIN GB0009252882FCA-NSM:4118924-0
    Canonical exit: 19 Dec 2021 (T+90)
  • ▲
    Non-Executive ChairmanExecutivesGlaxoSmithKline plc
    43,750 GBP0FCA-NSM
    3,113.879 shares@ £14.054.5% of flowN/AISIN GB0009252882FCA-NSM:4078201-0
    Canonical exit: 26 Oct 2021 (T+90)
  • ▲
    Non-Executive ChairmanExecutivesGlaxoSmithKline plc
    43,750 GBP0FCA-NSM
    3,264.925 shares@ £13.404.4% of flowN/AISIN GB0009252882FCA-NSM:3958103-0
    Canonical exit: 27 Jul 2021 (T+90)
  • ▲
    Non-Executive ChairmanExecutivesGlaxoSmithKline plc
    43,750 GBP0FCA-NSM
    3,214.548 shares@ £13.614.4% of flowN/AISIN GB0009252882FCA-NSM:3868580-0
    Canonical exit: 4 May 2021 (T+90)
  • ▼
    Non-Executive ChairmanExecutivesGlaxoSmithKline plc
    117,784 GBP8FCA-NSM
    8,944 shares@ £13.16911.4% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3765319-0
  • ▲
    Non-Executive ChairmanExecutivesGlaxoSmithKline plc
    197,310 GBP27FCA-NSM
    15,000 shares@ £13.15419.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3765319-1
    Canonical exit: 27 Jan 2021 (T+90)
  • ▲
    Non-Executive ChairmanExecutivesGlaxoSmithKline plc
    43,750 GBP0FCA-NSM
    3,240.741 shares@ £13.504.2% of flowN/AISIN GB0009252882FCA-NSM:3762711-0
    Canonical exit: 26 Jan 2021 (T+90)
  • ▲
    Non-Executive ChairmanExecutivesGlaxoSmithKline plc
    43,750 GBP0FCA-NSM
    2,753.304 shares@ £15.89100.0% of flowN/AISIN GB0009252882FCA-NSM:3671412-0
    Canonical exit: 27 Oct 2020 (T+90)
  • ▲
    Non-Executive ChairmanExecutivesGlaxoSmithKline plc
    43,750 GBP0FCA-NSM
    2,584.17 shares@ £16.934.4% of flowN/AISIN GB0009252882FCA-NSM:3585138-0
    Canonical exit: 28 Jul 2020 (T+90)
  • ▲
    Non-Executive ChairmanExecutivesGlaxoSmithKline plc
    199,997 GBP32FCA-NSM
    11,730 shares@ £17.0570.3% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20200206160002_3486866_20200331164939821_5967
    Canonical exit: 6 May 2020 (T+90)
  • ▲
    Non-Executive ChairmanExecutivesGlaxoSmithKline plc
    43,750 GBP0FCA-NSM
    2,430.556 shares@ £18.0015.4% of flowN/AISIN GB0009252882FCA-NSM:LSE20200205161501_3485422_20200331164939523_4518-0
    Canonical exit: 5 May 2020 (T+90)

14 of 14 declarations